Literature DB >> 24762600

Metformin ameliorates insulin resistance in L6 rat skeletal muscle cells through upregulation of SIRT3.

Yuping Song1, Jingli Shi1, Ying Wu1, Chong Han1, Junjie Zou1, Yongquan Shi1, Zhimin Liu2.   

Abstract

BACKGROUND: SIRT3 is an important regulator in cell metabolism, and recent studies have shown that it may be involved in the pharmacological effects of metformin. However, the molecular mechanisms underlying this process are unclear.
METHODS: The effects of SIRT3 on the regulation of oxidative stress and insulin resistance in skeletal muscle were evaluated in vitro. Differentiated L6 skeletal muscle cells were treated with 750 µmol/L palmitic acid to induce insulin resistance. SIRT3 was knocked down and overexpressed in L6 cells. SIRT3, nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) p65, c-Jun N-terminal kinase 1 (JNK1), and superoxide dismutase 2 (SOD2) were evaluated by Western blotting.
RESULTS: Over expression of SIRT3 increased glucose uptake and decreased ROS production in L6-IR cells as well as in L6 cells. Knock-down of SIRT3 induced increased production of ROS while decreased glucose uptake in both L6 and L6-IR cells, and these effects were reversed by N-acetyl-L-cysteine (NAC). Metformin increased the expression of SIRT3 (1.5-fold) and SOD2 (2-fold) while down regulating NF-κB p65 (1.5-fold) and JNK1 (1.5-fold). Knockdown of SIRT3 (P < 0.05) reversed the metformin-induced decreases in NF-κB p65 and JNK1 and the metformin-induced increase in SOD2 (P < 0.05).
CONCLUSIONS: Upregulated SIRT3 is involved in the pharmacological mechanism by which metformin promotes glucose uptake. Additionally, SIRT3 may function as an important regulator of oxidative stress and a new alternative approach for targeting insulin resistance-related diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24762600

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  9 in total

Review 1.  Using mitochondrial sirtuins as drug targets: disease implications and available compounds.

Authors:  Melanie Gertz; Clemens Steegborn
Journal:  Cell Mol Life Sci       Date:  2016-03-23       Impact factor: 9.261

2.  SIRT3-mediated inhibition of FOS through histone H3 deacetylation prevents cardiac fibrosis and inflammation.

Authors:  Xavier Palomer; M Silvia Román-Azcona; Javier Pizarro-Delgado; Ana Planavila; Francesc Villarroya; Brenda Valenzuela-Alcaraz; Fátima Crispi; Álvaro Sepúlveda-Martínez; Irene Miguel-Escalada; Jorge Ferrer; J Francisco Nistal; Raquel García; Mercy M Davidson; Emma Barroso; Manuel Vázquez-Carrera
Journal:  Signal Transduct Target Ther       Date:  2020-02-28

3.  Prenylflavonoids from fruit of Macaranga tanarius promote glucose uptake via AMPK activation in L6 myotubes.

Authors:  Noriyuki Natsume; Takayuki Yonezawa; Yukiko Saito; Je-Tae Woo; Toshiaki Teruya
Journal:  J Nat Med       Date:  2021-05-20       Impact factor: 2.343

Review 4.  Sirtuins-Mediated System-Level Regulation of Mammalian Tissues at the Interface between Metabolism and Cell Cycle: A Systematic Review.

Authors:  Parcival Maissan; Eva J Mooij; Matteo Barberis
Journal:  Biology (Basel)       Date:  2021-03-04

5.  Sirtuin-3 (SIRT3) protects pancreatic β-cells from endoplasmic reticulum (ER) stress-induced apoptosis and dysfunction.

Authors:  Hao-Hao Zhang; Xiao-Jun Ma; Li-Na Wu; Yan-Yan Zhao; Peng-Yu Zhang; Ying-Hui Zhang; Ming-Wei Shao; Fei Liu; Fei Li; Gui-Jun Qin
Journal:  Mol Cell Biochem       Date:  2016-07-23       Impact factor: 3.396

6.  A carnosine analog with therapeutic potentials in the treatment of disorders related to oxidative stress.

Authors:  Rita Rezzani; Gaia Favero; Matteo Ferroni; Claudio Lonati; Mohammed H Moghadasian
Journal:  PLoS One       Date:  2019-04-09       Impact factor: 3.240

Review 7.  Sirtuins as Important Factors in Pathological States and the Role of Their Molecular Activity Modulators.

Authors:  Ewa Maria Kratz; Katarzyna Sołkiewicz; Adriana Kubis-Kubiak; Agnieszka Piwowar
Journal:  Int J Mol Sci       Date:  2021-01-10       Impact factor: 5.923

8.  A Novel Role for SIRT3 in Regulating Mediators Involved in the Terminal Pathways of Human Labor and Delivery.

Authors:  Ratana Lim; Gillian Barker; Ramkumar Menon; Martha Lappas
Journal:  Biol Reprod       Date:  2016-09-14       Impact factor: 4.285

9.  SIRT3-mediated inhibition of FOS through histone H3 deacetylation prevents cardiac fibrosis and inflammation.

Authors:  Xavier Palomer; M Silvia Román-Azcona; Javier Pizarro-Delgado; Ana Planavila; Francesc Villarroya; Brenda Valenzuela-Alcaraz; Fátima Crispi; Álvaro Sepúlveda-Martínez; Irene Miguel-Escalada; Jorge Ferrer; J Francisco Nistal; Raquel García; Mercy M Davidson; Emma Barroso; Manuel Vázquez-Carrera
Journal:  Signal Transduct Target Ther       Date:  2020-02-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.